Cargando…
Challenges in IgA Nephropathy Management: An Era of Complement Inhibition
IgA nephropathy (IgAN) is the most common glomerular disease worldwide, with an estimated annual incidence of 25 per million adults. Despite optimized supportive care, some patients fail to achieve disease control and suffer progressive deterioration of kidney function. In this subpopulation of pati...
Autores principales: | Tesař, Vladimir, Radhakrishnan, Jai, Charu, Vivek, Barratt, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496078/ https://www.ncbi.nlm.nih.gov/pubmed/37705895 http://dx.doi.org/10.1016/j.ekir.2023.06.010 |
Ejemplares similares
-
International Physicians Delphi Survey: Managing Patients With IgA Nephropathy
por: Floege, Jürgen, et al.
Publicado: (2022) -
Emerging Modes of Treatment of IgA Nephropathy
por: Maixnerova, Dita, et al.
Publicado: (2020) -
Why Target the Gut to Treat IgA Nephropathy?
por: Barratt, Jonathan, et al.
Publicado: (2020) -
Role of complement in IgA nephropathy
por: Daha, Mohamed R., et al.
Publicado: (2015) -
Complement activation in IgA nephropathy
por: Medjeral-Thomas, Nicholas R., et al.
Publicado: (2021)